Your browser doesn't support javascript.
loading
Self-reported antibiotic stewardship and infection control measures from 57 intensive care units: An international ID-IRI survey.
El-Sokkary, Rehab; Erdem, Hakan; Kullar, Ravina; Pekok, Abdullah Umut; Amer, Fatma; Grgic, Svjetlana; Carevic, Biljana; El-Kholy, Amani; Liskova, Anna; Özdemir, Mehmet; Khan, Ejaz Ahmed; Kizmaz, Yesim Uygun; Pandak, Nenad; Pandya, Nirav; Arapovic, Jurica; Karaali, Ridvan; Oztoprak, Nefise; Petrov, Michael M; Alabadla, Rami; Alay, Handan; El Kholy, Jehan Ali; Landelle, Caroline; Khedr, Reham; Mamtora, Dhruv; Dragovac, Gorana; Fernandez, Ricardo; Evren, Emine Unal; Raka, Lul; Cascio, Antonio; Dauby, Nicolas; Oncul, Ahsen; Balin, Safak Ozer; Cag, Yasemin; Dirani, Natalia; Dogan, Mustafa; Dumitru, Irina Magdalena; Gad, Maha Ali; Darazam, Ilad Alavi; Naghili, Behrouz; Del Vecchio, Rosa Fontana; Licker, Monica; Marino, Andrea; Akhtar, Nasim; Kamal, Mostafa; Angioni, Goffredo; Medic, Deana; Esmaoglu, Aliye; Gergely, Szabo Balint; Silva-Pinto, André; Santos, Lurdes.
Afiliação
  • El-Sokkary R; Department of Medical Microbiology and Immunology, Faculty of medicine, Zagazig University, Egypt.
  • Erdem H; ID-IRI Lead Coordinator, Ankara, Turkey. Electronic address: hakanerdem1969@yahoo.com.
  • Kullar R; Expert Stewardship, Inc., Los Angeles, CA, USA.
  • Pekok AU; Department of Infectious Diseases and Clinical Microbiology, Bahcesehir University Medicine of Faculty, Turkey.
  • Amer F; Department of Medical Microbiology and Immunology, Faculty of medicine, Zagazig University, Egypt.
  • Grgic S; Department of Infectious Diseases, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina.
  • Carevic B; Clinical Center of Serbia, Belgrade, Serbia.
  • El-Kholy A; Department of Clinical Pathology, Faculty of Medicine, Cairo University, Egypt.
  • Liskova A; Hospital Nitra, Nitra, Slovak Republic.
  • Özdemir M; Necmettin Erbakan University, Meram Faculty of Medicine, Turkey.
  • Khan EA; Shifa International Hospital, Islamabad, Pakistan.
  • Kizmaz YU; Kartal Kosuyolu High Specialization Training and Research Hospital, Turkey.
  • Pandak N; The Royal Hospital, Muscat, Oman.
  • Pandya N; Bhailal Amin General Hospital, Gujarat, India.
  • Arapovic J; Department of Infectious Diseases, University Clinical Hospital Mostar, Mostar, Bosnia and Herzegovina; School of Medicine University of Mostar, Mostar, Bosnia and Herzegovina.
  • Karaali R; Istanbul University, Cerrahpasa Medical Faculty, Istanbul, Turkey.
  • Oztoprak N; Health Sciences University Antalya Training and Research Hospital, Turkey.
  • Petrov MM; St. George" University Hospital, Plovdiv, Bulgaria.
  • Alabadla R; European Gaza Hospital (EGH), Gaza, Palestine.
  • Alay H; Ataturk University, School of Medicine, Erzurum, Turkey.
  • El Kholy JA; Department of Anesthesiology and Intensive Care, Faculty of Medicine, Cairo University, Egypt.
  • Landelle C; CHU Grenoble Alpes, France.
  • Khedr R; Department of Pediatric Oncology, National Cancer Institute - Cairo University / Children Cancer Hospital Egypt 57357, Egypt.
  • Mamtora D; SL Raheja Hospital, Mumbai, India.
  • Dragovac G; Clinical Center of Vojvodina, Novi Sad, Serbia.
  • Fernandez R; Hospital Municipal de San Juan, Puerto Rico.
  • Evren EU; University of Kyrenia, Dr. Suat Gunsel Hospital, Cyprus.
  • Raka L; National Institute of Public Health of Kosova & University "Hasan Prishtina", Prishtina, Kosova.
  • Cascio A; AOU Policlinico "P. Giaccone", Palermo, Italy.
  • Dauby N; Environmental Health Research Centre, Public Health School, Université Libre de Bruxelles (ULB), Brussels, Belgium.
  • Oncul A; Sisli Hamidiye Etfal Education and Research Hospital, Istanbul, Turkey.
  • Balin SO; Firat University Medical Faculty Hospital, Elazig, Turkey.
  • Cag Y; Istanbul Medeniyet University, Goztepe Training and Research Hospital, Istanbul, Turkey.
  • Dirani N; Dar al Amal University Hospital, Douris, Lebanon.
  • Dogan M; Namik Kemal University School of Medicine, Hatay, Turkey.
  • Dumitru IM; Clinical Infectious Diseases Hospital Constanta, Ovidius University of Constanta, Romania.
  • Gad MA; Kasr Eliny Hospital, Cairo, Egypt.
  • Darazam IA; Loghman Hakim Hospital, Tehran, Iran.
  • Naghili B; Imam Reza hospital of Tabriz University of Medical Sciences), Iran.
  • Del Vecchio RF; Department of Clinical and Molecular Biomedicine, Division of Infectious Diseases, University of Catania, Garibaldi Nesima Hospital, Catania, Italy.
  • Licker M; Victor Babes University of Medicine and Pharmacy Timisoara, Romania.
  • Marino A; Arnas Garibaldi Hospital, Catania, Italy.
  • Akhtar N; Pakistan Institute of Medical Sciences, Islamabad, Pakistan.
  • Kamal M; ICU, RMCH, Rajshahi, Bangladesh.
  • Angioni G; SS. Trinita' Hospital, Cagliari, Italy.
  • Medic D; Institute for Child Health of Vojvodina, Serbia.
  • Esmaoglu A; Erciyes University Medical School Hospital, Kayseri, Turkey.
  • Gergely SB; South Pest Central Hospital, National Institute of Hematology and Infectious Diseases, Saint Ladislaus Campus, Budapest, Hungary.
  • Silva-Pinto A; Centro Hospitalar Universitário de São João, Portugal.
  • Santos L; Centro Hospitalar Universitário de São João, Portugal.
J Infect Public Health ; 15(9): 950-954, 2022 Sep.
Article em En | MEDLINE | ID: mdl-35917656
ABSTRACT
We explored the self-reported antibiotic stewardship (AS), and infection prevention and control (IPC) activities in intensive care units (ICUs) of different income settings. A cross-sectional study was conducted using an online questionnaire to collect data about IPC and AS measures in participating ICUs. The study participants were Infectious Diseases-International Research Initiative (IDI-IR) members, committed as per their institutional agreement form. We analyzed responses from 57 ICUs in 24 countries (Lower-middle income (LMI), n = 13; Upper-middle income (UMI), n = 33; High-income (HI), n = 11). This represented (~5%) of centers represented in the ID-IRI. Surveillance programs were implemented in (76.9%-90.9%) of ICUs with fewer contact precaution measures in LMI ones (p = 0.02); (LMI69.2%, UMI97%, HI100%). Participation in regional antimicrobial resistance programs was more significantly applied in HI (p = 0.02) (LMI38.4%,UMI81.8%,HI72.2%). AS programs are implemented in 77.2% of institutions with AS champions in 66.7%. Infectious diseases physicians and microbiologists are members of many AS teams (59%&50%) respectively. Unqualified healthcare professionals(42.1%), and deficient incentives(28.1%) are the main barriers to implementing AS. We underscore the existing differences in IPC and AS programs' implementation, team composition, and faced barriers. Continuous collaboration and sharing best practices on APM is needed. The role of regional and international organizations should be encouraged. Global support for capacity building of healthcare practitioners is warranted.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecção Hospitalar / Doenças Transmissíveis / Gestão de Antimicrobianos Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Egito

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecção Hospitalar / Doenças Transmissíveis / Gestão de Antimicrobianos Idioma: En Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Egito